Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI

Scand Cardiovasc J. 2004 Mar;38(1):9-15. doi: 10.1080/14017430310016199.
No abstract available

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Clinical Trials as Topic
  • Clopidogrel
  • Drug Therapy, Combination
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / adverse effects
  • Heparin / therapeutic use
  • Humans
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Glycoprotein GPIIb-IIIa Complex / adverse effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Heparin
  • Clopidogrel
  • Ticlopidine
  • Aspirin